Drugs and Therapeutics (D & T) Committee Meeting Results for: March 18, 2015
Drug Name | Review Type | Committee Recommendation | Prior Approval Status � Final Determination |
---|---|---|---|
Viekira Pak | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Zontivity | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Harvoni | New Drug Initial Review | Add to Preferred Status | Preferred and Require Prior Approval |
Savaysa | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Grastek | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Ragwitek | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Plegridy | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
Orbactiv | New Drug Initial Review | Remove Prior Approval Requirement | Prior Approval Required |